[{"headers": [["Condensed Consolidated Statements of Operations - USD ($) shares in Millions, $ in Millions", "3 Months Ended"], ["Mar. 30, 2019", "Mar. 31, 2018"]], "sections": ["Income Statement [Abstract]", "Earnings per share", "Shares used in per share calculation"], "data": [["Net revenue", "$ 1,272", "$ 1,647"], ["Cost of sales", "751", "1,050"], ["Gross margin", "521", "597"], ["Research and development", "373", "343"], ["Marketing, general and administrative", "170", "134"], ["Licensing gain", "(60)", "0"], ["Operating income", "38", "120"], ["Interest expense", "(27)", "(31)"], ["Other income (expense), net", "(7)", "1"], ["Income before income taxes and equity loss", "4", "90"], ["Provision (benefit) for income taxes", "(13)", "8"], ["Equity loss in investee", "(1)", "(1)"], ["Net income", "$ 16", "$ 81"], ["Basic (in usd per share)", "$ 0.01", "$ 0.08"], ["Diluted (in usd per share)", "$ 0.01", "$ 0.08"], ["Basic (in shares)", "1,044", "968"], ["Diluted (in shares)", "1,094", "1,039"]]}, {"headers": [["Condensed Consolidated Balance Sheets - USD ($) $ in Millions", "Mar. 30, 2019", "Dec. 29, 2018"]], "sections": ["Current assets:", "Current liabilities:", "Capital stock:"], "data": [["Cash and cash equivalents", "$ 978", "$ 1,078"], ["Marketable securities", "216", "78"], ["Accounts receivable, net", "1,241", "1,235"], ["Inventories, net", "955", "845"], ["Prepayment and receivables\u2014related parties", "50", "52"], ["Prepaid expenses", "65", "57"], ["Other current assets", "172", "195"], ["Total current assets", "3,677", "3,540"], ["Property and equipment, net", "377", "348"], ["Operating lease right-of-use assets", "214", "0"], ["Goodwill", "289", "289"], ["Investment: equity method", "57", "58"], ["Other assets", "317", "321"], ["Total assets", "4,931", "4,556"], ["Short-term debt, net", "70", "136"], ["Accounts payable", "484", "528"], ["Payables to related parties", "446", "533"], ["Accrued liabilities", "719", "763"], ["Other current liabilities", "45", "24"], ["Total current liabilities", "1,764", "1,984"], ["Long-term debt, net", "1,024", "1,114"], ["Long-term operating lease liabilities", "213", "0"], ["Other long-term liabilities", "142", "192"], ["Contingencies (See Note 12)", "", ""], ["Common stock, par value $0.01; shares authorized: 2,250; shares issued: 1,087 and 1,010; shares outstanding: 1,082 and 1,005", "11", "10"], ["Additional paid-in capital", "9,246", "8,750"], ["Treasury stock, at cost (shares issued: 5 and 5)", "(48)", "(50)"], ["Accumulated deficit", "(7,420)", "(7,436)"], ["Accumulated other comprehensive loss", "(1)", "(8)"], ["Total stockholders\u2019 equity", "1,788", "1,266"], ["Total liabilities and stockholders\u2019 equity", "$ 4,931", "$ 4,556"]]}, {"headers": [["Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions", "3 Months Ended"], ["Mar. 30, 2019", "Mar. 31, 2018"]], "sections": ["Cash flows from operating activities:", "Adjustments to reconcile net income to net cash used in operating activities:", "Changes in operating assets and liabilities:", "Cash flows from investing activities:", "Cash flows from financing activities:", "Non-cash activities:", "Reconciliation of cash, cash equivalents, and restricted cash"], "data": [["Net income", "$ 16", "$ 81"], ["Depreciation and amortization", "46", "44"], ["Stock-based compensation", "41", "32"], ["Amortization of debt discount and issuance costs", "9", "10"], ["Loss on debt redemption", "8", "1"], ["Loss on sale/disposal of property and equipment", "6", "0"], ["Other", "(1)", "1"], ["Accounts receivable", "(5)", "(295)"], ["Inventories", "(110)", "(21)"], ["Prepayment and receivables - related parties", "2", "15"], ["Prepaid expenses and other assets", "(11)", "24"], ["Payables to related parties", "(87)", "(38)"], ["Accounts payable, accrued liabilities and other", "(127)", "39"], ["Net cash used in operating activities", "(213)", "(107)"], ["Purchases of property and equipment", "(62)", "(46)"], ["Purchases of available-for-sale debt securities", "(231)", "0"], ["Proceeds from maturity of available-for-sale debt securities", "93", "0"], ["Collection of deferred proceeds on sale of receivables", "25", "21"], ["Other", "2", "0"], ["Net cash used in investing activities", "(173)", "(25)"], ["Proceeds from warrant exercise by related party", "449", "0"], ["Proceeds from issuance of common stock through employee equity incentive plans", "1", "6"], ["Repayments of long-term debt", "(164)", "(14)"], ["Net cash provided by (used in) financing activities", "286", "(8)"], ["Net decrease in cash, cash equivalents, and restricted cash", "(100)", "(140)"], ["Cash, cash equivalents, and restricted cash at beginning of period", "1,083", "1,191"], ["Cash, cash equivalents, and restricted cash at end of period", "983", "1,051"], ["Purchases of property and equipment, accrued but not paid", "62", "47"], ["Issuance of treasury stock to partially settle debt", "7", "0"], ["Deferred proceeds on sale of receivables", "0", "11"], ["Other", "3", "0"], ["Cash and cash equivalents", "978", "1,045"], ["Restricted cash included in Other current assets", "5", "3"], ["Restricted cash included in Other assets", "0", "3"], ["Total cash, cash equivalents, and restricted cash", "$ 1,083", "$ 1,191"]]}, {"headers": [["Consolidated Statements of Stockholders' Equity - USD ($) $ in Millions", "Total", "Common Stock", "Additional paid-in capital", "Treasury stock", "Accumulated deficit", "Accumulated other comprehensive income (loss)"]], "sections": ["Changes in Accumulated Other Comprehensive Income (Loss) [Roll Forward]", "Changes in Accumulated Other Comprehensive Income (Loss) [Roll Forward]"], "data": [["Beginning balance at Dec. 30, 2017", "", "$ 9", "$ 8,464", "$ (108)", "$ (7,775)", "$ 6"], ["Common stock issued under employee equity incentive plans, net of tax withholding", "", "1", "6", "", "", ""], ["Issuance of common stock upon warrant exercise", "", "0", "0", "", "", ""], ["Stock-based compensation", "", "", "32", "", "", ""], ["Issuance of treasury stock to partially settle debt", "", "", "0", "0", "", ""], ["Other", "", "", "0", "", "", ""], ["Net income", "$ 81", "", "", "", "81", ""], ["Cumulative effect adjustment to accumulated deficit related to the adoption of ASU 2016-01, Financial Instruments", "2", "", "", "", "", ""], ["Cumulative effect adjustment to accumulated deficit related to the adoption of ASU 2016-01, Financial Instruments | Accounting Standards Update 2016-01", "", "", "", "", "2", ""], ["Other comprehensive income (loss)", "(3)", "", "", "", "", "(3)"], ["Ending balance at Mar. 31, 2018", "715", "10", "8,502", "(108)", "(7,692)", "3"], ["Beginning balance at Dec. 29, 2018", "1,266", "10", "8,750", "(50)", "(7,436)", "(8)"], ["Common stock issued under employee equity incentive plans, net of tax withholding", "", "0", "1", "", "", ""], ["Issuance of common stock upon warrant exercise", "", "1", "448", "", "", ""], ["Stock-based compensation", "", "", "41", "", "", ""], ["Issuance of treasury stock to partially settle debt", "", "", "5", "2", "", ""], ["Other", "", "", "1", "", "", ""], ["Net income", "16", "", "", "", "16", ""], ["Cumulative effect adjustment to accumulated deficit related to the adoption of ASU 2016-01, Financial Instruments", "0", "", "", "", "", ""], ["Cumulative effect adjustment to accumulated deficit related to the adoption of ASU 2016-01, Financial Instruments | Accounting Standards Update 2016-01", "", "", "", "", "0", ""], ["Other comprehensive income (loss)", "7", "", "", "", "", "7"], ["Ending balance at Mar. 30, 2019", "$ 1,788", "$ 11", "$ 9,246", "$ (48)", "$ (7,420)", "$ (1)"]]}]